Navigation Links
CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
Date:5/16/2008

VIENNA, Va., May 16 /PRNewswire-FirstCall/ -- CEL-SCI CORPORATION (Amex: CVM) reports financial results for the three and six months ended March 31, 2008.

Geert Kersten, Chief Executive Officer of CEL-SCI Corporation said, "We are completely focused on getting our cancer therapy Multikine(R) into its pivotal Phase III clinical trial. We were unable to start the Phase III study until the completion of our dedicated manufacturing facility for Multikine from which we can supply the Phase III study and subsequent sale of the drug. This facility is expected to be completed in the 3rd quarter of 2008. The Phase III study is designed to replicate the safety and efficacy results seen in the earlier studies and lead to an approval to sell Multikine."

Mr. Kersten continued, "Our financial results reflect our primary focus on the facility and preparation for the Phase III trial. Our Phase III trial is the first Phase III trial to test the theory that immune stimulation before surgery, radiation and/or chemotherapy will increase survival of cancer patients."

About Multikine:

In Phase II clinical trials Multikine was shown to be safe and well-tolerated, and to improve the patients' overall survival by 33% at a median of three and a half years following surgery. The U.S. Food and Drug Administration (FDA) gave the go-ahead for a Phase III clinical trial with Multikine in January 2007 and granted orphan drug status to Multikine in the neoadjuvant therapy of squamous cell carcinoma (cancer) of the head and neck in May 2007.

CEL-SCI is currently building a manufacturing facility for Multikine close to Baltimore, MD. Upon completion of the facility in the 3rd quarter of 2008, CEL-SCI will commence the Phase III clinical tr
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
4. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
5. RediStat Corporation Partners With ALERT FM for Disaster-Proof Emergency Communications
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2008
7. Diagnostic Health Corporation Names Robert E. Gontarek as COO
8. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
9. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
10. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
11. CRH Medical Corporation opens Center in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... -- Although spring arrived late this year in parts ... still be strong, according to a sinus expert at ... Waguespack, clinical professor in the university,s division of otolaryngology, ... summer allergy season. However, some simple strategies can help ... he added. "Tree pollen has been bad for ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic ... of the lowest unemployment rates in the country. Forbes Magazine ... for Business and Careers and it consistently scores high on ... located in the nation and is a strong business leader ... of Editions TV are pleased to announce air ...
(Date:5/19/2013)... Park City, Utah (PRWEB) May 19, 2013 ... new information on small business health insurance ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... businesses, start-ups, and the self-employed intrinsically know the ...
(Date:5/19/2013)... 19, 2013 The report “Feed Additives ... & Forecasts up to 2017” published by MarketsandMarkets, defines ... analysis and forecasting of the global volume and revenue ... driving and restraining factors for the global market with ... challenges. The market is segmented and revenue is forecasted ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Dr. Keith Chertok ... help fight their unhealthy gums and increase the chance of ... Laser Assisted New Attachment Procedure (LANAP) not only removes diseased ... and strengthens the jaw bone for dental implants. ... diseased gum tissue. It can also help stimulate the healthy ...
Breaking Medicine News(10 mins):Health News:Managing Seasonal Allergies 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
... have not noticed a restriction in their access to ... Improvement and Modernization Act of 2003 (MMA), despite the ... to a new study led by researchers in the ... MMA often said that it would reduce patients access ...
... BEND, Ind., Oct. 7 OCS, Inc. and,Press ... into a,partnership, whereby the companies have combined their ... of products for the home,health care industry. The ... analysis of interrelated performance metrics integrating,patient satisfaction, patient ...
... They help ward off osteoarthritis, study suggests , TUESDAY, ... health may also help keep knee cartilage healthy and ... studies on the issue have produced conflicting findings, the ... knee osteoarthritis, while other studies found that exercise may ...
... Several medical groups,affiliated and aligned with Sutter ... the independent and highly respected health care leadership,group, ... part,of the IHA,s annual Pay for Performance (P4P) ... top performance are,Solano Regional Medical Group of the ...
... Following its recent,merger with Echo Therapeutics, Inc., ... platform-enabled transdermal specialty,therapeutics and diagnostics company, today announced ... Therapeutics, Inc., effective Monday, October 8,2007. In addition, ... Board,ticker symbol will change to "ECTE" and its ...
... and audio web cast on October 9, 2007 --, BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - ... Agriculture,(USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine,during a: ... Conference Call & Audio Web Cast ... Tuesday, October 9, 2007 ...
Cached Medicine News:Health News:Medicare modernization act did not change chemotherapy as feared 2Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Heart-Healthy Workouts Help Knees, Too 2Health News:Sutter Health Medical Groups Among the Best for Health Care Quality 2Health News:Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc. 2
(Date:5/17/2013)... , May 17, 2013 The power ... most important ways in which mankind depends on the ... Botanical Garden,s multifaceted exhibition Wild Medicine: ... Garden, on view from May 18 through September ... The featured exhibition,s many attractions include a ...
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
(Date:5/17/2013)... 2013   Shareholder rights attorneys  at Robbins Arroyo ... (NASDAQGS: AVEO) securities has filed a complaint in the ... Massachusetts .  The complaint alleges that Aveo and ... of 1934 (the "Exchange Act") between January 3, 2012 ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) Aveo ...
Breaking Medicine Technology:Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
... ANGELES, June 17, 2011 Damage to the spine can ... or fall, car accident, wear and tear from old age, ... in the past have had to deal with back braces, ... with Dr. Seyed M. Rezaian,s patented Spinal Fixator, patients are ...
... N.J., June 17, 2011 Ortho-McNeil-Janssen Pharmaceuticals, Inc. ... of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen ... of risperidone 2mg Tablets, marketed by Patriot Pharmaceuticals, ... Inc.  The recalls stem from two consumer reports ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 2Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 3Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 4Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 5Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 6Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets 7
... smoke evacuator is the ... smoke evacuation system when ... smoke evacuation attachment, Valleylab's ... either the Force FX™ ...
Simple, stable knee positioning triangles for lower extremity surgery. The triangles are radiolucent, autoclavable, and use latex-free, sterile, disposable pads....
Turnstile casting stand for easy and safe casting. The compact system sets up quickly and stores conveniently, and the non-stick coating prevents fiberglass or plaster from adhering to surface....
... optimal leg position for the seated patient and ... the foot/ankle at 90 degrees to the leg. ... the stand. Stockinette is pulled over the foot ... in a routine fashion. The cast stand is ...
Medicine Products: